MCC
AGN

Mid Continent Capital’s Allergan plc AGN Stock Holding History

Mid Continent Capital’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		$27.7M Buy
101,961
+13,209
+15% +$4.06M 1.8% 16
2015
Q2 		$26.9M Buy
88,752
+69,843
+369% +$20.8M 1.49% 18
2015
Q1 		$5.63M Buy
+18,909
New +$5.39M 0.31% 75

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return
PC
Paulson & Co New York $3.11B AUM 94.93% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

Mid Continent Capital's AGN Position: Q3 2015 in Review

Mid Continent Capital increased its Allergan plc (AGN) stake by 15% in Q3 2015, buying an estimated $4.06M and bringing the position to 101,961 shares worth $27.7M. The position accounts for 1.8% of the portfolio, ranked #16.

Mid Continent Capital first reported a position in AGN in Q1 2015 and has held it in 3 quarters since. 1,056 funds tracked by Wall St. Rank hold AGN as of Q3 2015.

  • Mid Continent Capital held 101,961 shares of Allergan plc worth $27.7M as of Q3 2015.
  • Mid Continent Capital bought 13,209 Allergan plc shares in Q3 2015, an estimated $4.06M.
  • Allergan plc made up 1.8% of Mid Continent Capital's portfolio in Q3 2015, its #16 holding.
  • Mid Continent Capital first reported a position in Allergan plc in Q1 2015 and has held it in 3 quarters since.
  • 1,056 funds tracked by Wall St. Rank held Allergan plc as of Q3 2015.

Based on Mid Continent Capital's 13F filing for Q3 2015, filed 22 Oct 2015.